Skip Navigation


Brain Advance Access originally published online on February 4, 2007
Brain 2007 130(3):828-835; doi:10.1093/brain/awl340
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
130/3/828    most recent
awl340v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brashear, A.
Right arrow Articles by Ozelius, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brashear, A.
Right arrow Articles by Ozelius, L. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2007). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The phenotypic spectrum of rapid-onset dystonia–parkinsonism (RDP) and mutations in the ATP1A3 gene

Allison Brashear1, William B. Dobyns2, Patricia de Carvalho Aguiar3,7, Michel Borg8, C. J. M. Frijns9, Seema Gollamudi3, Andrew Green11, João Guimaraes13, Bret C. Haake5, Christine Klein14, Gurutz Linazasoro16, Alexander Münchau15, Deborah Raymond4, David Riley6, Rachel Saunders-Pullman4, Marina A. J. Tijssen10, David Webb12, Jacek Zaremba17, Susan B. Bressman4 and Laurie J. Ozelius3

1Department of Neurology, Wake Forest University, Winston Salem, NC, 2Departments of Human Genetics, Neurology and Pediatrics, The University of Chicago, Chicago, IL, 3Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, 4Department of Neurology, Beth Israel Medical Center, New York, NY, 5Meritcare Neuroscience, Fargo, ND, 6Department of Neurology, University Hospital of Cleveland, Cleveland, OH, USA, 7Department of Neurology and Neurosurgery, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Sao Paulo-SP, Brazil, 8Service de Neurologie Centre Hospitalier, Universitaire de Nice, Nice, France, 9Department of Neurology, University Medical Centre Utrecht, The Netherlands, 10Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands, 11National Center for Medical Genetics, Our Lady's Hospital, Crumlin, Dublin, Ireland, 12Pediatric Neurology, Our Lady's Hospital, Crumlin, Northern Ireland, UK, 13Hospital De Egas Moniz, Universidade Nova de Lisboa, Lisboa, Portugal, 14Department of Neurology, Medical University of Lübeck, Lübeck, Germany, 15Department of Neurology, University of Hamburg, Hamburg, Germany, 16Centro de Investigación Parkinson, Policlínica Gipuzkoa, San Sebastián, Spain and 17Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland

Corresponding author: Allison Brashear, MD, Department of Neurology, Wake Forest University, Meads Hall 3rd Floor, Medical Center Boulevard, Winston Salem, NC 27157, USA E-mail: abrashea{at}wfubmc.edu

Rapid-onset dystonia–parkinsonism (RDP) (also known as DYT12) is characterized by the abrupt onset of dystonia and parkinsonism and is caused by mutations in the ATP1A3 gene. We obtained clinical data and sequenced the ATP1A3 gene in 49 subjects from 21 families referred with ‘possible’ RDP, and performed a genotype–phenotype analysis. Of the new families referred for study only 3 of 14 families (21%) demonstrated a mutation in the ATP1A3 gene, but no new mutations were identified beyond our earlier report of 6. Adding these to previously reported families, we found mutations in 36 individuals from 10 families including 4 de novo mutations and excluded mutations in 13 individuals from 11 families. The phenotype in mutation positive patients included abrupt onset of dystonia with features of parkinsonism, a rostrocaudal gradient, and prominent bulbar findings. Other features found in some mutation carriers included common reports of triggers, minimal or no tremor at onset, occasional mild limb dystonia before the primary onset, lack of response to dopaminergic medications, rare abrupt worsening of symptoms later in life, stabilization of symptoms within a month and minimal improvement overall. In comparing ATP1A3 mutation positive and negative patients, we found that tremor at onset of symptoms, a reversed rostrocaudal gradient, and significant limb pain exclude a diagnosis of RDP. A positive family history is not required. Genetic testing for the ATP1A3 gene is recommended when abrupt onset, rostrocaudal gradient and prominent bulbar findings are present.

Key Words: ATP1A3; dystonia; Na+/K+-ATPase; parkinsonism; rapid-onset dystonia–parkinsonism; RDP

Received July 26, 2006. Revised September 26, 2006. Accepted November 9, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
U. Muller
The monogenic primary dystonias
Brain, July 3, 2009; (2009) awp172v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Blanco-Arias, A. P. Einholm, H. Mamsa, C. Concheiro, H. Gutierrez-de-Teran, J. Romero, M. S. Toustrup-Jensen, A. Carracedo, J. C. Jen, B. Vilsen, et al.
A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism
Hum. Mol. Genet., July 1, 2009; 18(13): 2370 - 2377.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Schmidt, H. -C. Jabusch, E. Altenmuller, J. Hagenah, N. Bruggemann, K. Lohmann, L. Enders, P. L. Kramer, R. Saunders-Pullman, S. B. Bressman, et al.
Etiology of musician's dystonia: Familial or environmental?
Neurology, April 7, 2009; 72(14): 1248 - 1254.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.